Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Browsing Tag

relapsing multiple sclerosis

3 posts
RRoche
Genentech persevERA breast cancer trial misses PFS goal
Read More

Genentech fenebrutinib cuts relapsing MS relapses 51%-59%

  • 2026-05-02
04/21/2026 – 07:15 PM Late-breaking Phase III FENhance 1 and 2 study results showed superiority of investigational fenebrutinib…
RRoche
Levi Garraway, Roche’s Chief Medical Officer and Head of Global Product Development
Read More

Roche’s fenebrutinib cuts relapses in MS amid safety concerns

  • 2026-04-22
Roche is hoping to bring the the first and only high-efficacy oral for both relapsing multiple sclerosis (RMS)…
RRoche
Genentech persevERA breast cancer trial misses PFS goal
Read More

Roche fenebrutinib cuts RMS relapses 51%-59%

  • 2026-04-22
Roche (OTCQX: RHHBY) reported that investigational fenebrutinib met primary endpoints in Phase III…
Switzerland
www.europesays.com